Terray

Terray Therapeutics: Built at the Intersection of AI and Experimentation

Founded 2018 · $120.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$120.0M
Last Round
$120.0M Series BOct 2024
Rounds
1

About

Terray Therapeutics invents its own hardware, builds its own datasets, and designs its own AI to reimagine small molecule drug discovery. The company's integrated computational and experimental platforms generate scaled chemical data purpose-built to power computational learning and reveal new interactions. Terray's chemistry engine measures biochemical interactions between small molecules and disease causes, combining ultra-dense microarray technology with machine learning to navigate chemical space and deliver more precise therapies to patients.

Summary

Terray is an Artificial Intelligence company, founded in 2018. It has raised $120.0M in total across 1 round, most recently a $120.0M Series B round in Oct 2024. Investors include Bedford Ridge Capital, nVentures and Maverick Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2024
$120.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Terray on Indexed.vc
<a href="https://indexed.vc/companies/terray"><img src="https://indexed.vc/api/badge/company/terray" alt="Terray on Indexed.vc" width="260" height="76" /></a>